PGS Publication: PGP000620

Publication Information (EuropePMC)
Title Case-Case Genome-Wide Analyses Identify Subtype-Informative Variants that Confer Risk for Breast Cancer.
PubMed ID 38832928(Europe PMC)
doi 10.1158/0008-5472.can-23-3854
Publication Date June 4, 2024
Journal Cancer Res
Author(s) Sun X, Verma SP, Jia G, Wang X, Ping J, Guo X, Shu XO, Chen J, Derkach A, Cai Q, Liang X, Long J, Offit K, Oh JH, Reiner AS, Watt GP, Woods M, Yang Y, Ambrosone CB, Ambs S, Chen Y, Concannon P, Garcia-Closas M, Gu J, Haiman CA, Hu JJ, Huo D, John EM, Knight JA, Li CI, Lynch CF, Mellemkjaer L, Nathanson KL, Nemesure B, Olopade OI, Olshan AF, Pal T, Palmer JR, Press MF, Sanderson M, Sandler DP, Troester MA, Zheng W, Bernstein JL, Buas MF, Shu X.
Released in PGS Catalog: June 12, 2024

Associated Polygenic Score(s)

Filter PGS by Participant Ancestry
Individuals included in:
G - Source of Variant Associations (GWAS)
D - Score Development/Training
E - PGS Evaluation
List of ancestries includes:
Display options:
Ancestry legend
Multi-ancestry (including European)
Multi-ancestry (excluding European)
African
East Asian
South Asian
Additional Asian Ancestries
European
Greater Middle Eastern
Hispanic or Latin American
Additional Diverse Ancestries
Not Reported

PGS Developed By This Publication

Polygenic Score ID & Name PGS Publication ID (PGP) Reported Trait Mapped Trait(s) (Ontology) Number of Variants Ancestry distribution
GWAS
Dev
Eval
Scoring File (FTP Link)
PGS004892
(TNBC_PRS41)
PGP000620 |
Sun X et al. Cancer Res (2024)
Triple negative breast cancer triple-negative breast cancer 41
-
https://ftp.ebi.ac.uk/pub/databases/spot/pgs/scores/PGS004892/ScoringFiles/PGS004892.txt.gz
PGS004890
(CC-GWAS_PRS)
PGP000620 |
Sun X et al. Cancer Res (2024)
Triple negative breast cancer versus luminal breast cancer triple-negative breast cancer 25
-
https://ftp.ebi.ac.uk/pub/databases/spot/pgs/scores/PGS004890/ScoringFiles/PGS004890.txt.gz
PGS004891
(TNBC_PRS25)
PGP000620 |
Sun X et al. Cancer Res (2024)
Triple negative breast cancer triple-negative breast cancer 25
-
https://ftp.ebi.ac.uk/pub/databases/spot/pgs/scores/PGS004891/ScoringFiles/PGS004891.txt.gz

Performance Metrics

Disclaimer: The performance metrics are displayed as reported by the source studies. It is important to note that metrics are not necessarily comparable with each other. For example, metrics depend on the sample characteristics (described by the PGS Catalog Sample Set [PSS] ID), phenotyping, and statistical modelling. Please refer to the source publication for additional guidance on performance.

PGS Performance
Metric ID (PPM)
Evaluated Score PGS Sample Set ID
(PSS)
Performance Source Trait PGS Effect Sizes
(per SD change)
Classification Metrics Other Metrics Covariates Included in the Model PGS Performance:
Other Relevant Information
PPM021271 PGS004891
(TNBC_PRS25)
PSS011672|
Multi-ancestry (including European)|
9,868 individuals
PGP000620 |
Sun X et al. Cancer Res (2024)
Reported Trait: Triple negative breast cancer Odds ratio (OR, high vs low tertile): 1.54 [0.92, 2.59] Age at initial pathologic diagnosis of breast cancer, pathologic stage
PPM021272 PGS004892
(TNBC_PRS41)
PSS011672|
Multi-ancestry (including European)|
9,868 individuals
PGP000620 |
Sun X et al. Cancer Res (2024)
Reported Trait: Triple negative breast cancer Odds ratio (OR, high vs low tertile): 1.53 [0.92, 2.55] Age at initial pathologic diagnosis of breast cancer, pathologic stage
PPM021270 PGS004890
(CC-GWAS_PRS)
PSS011672|
Multi-ancestry (including European)|
9,868 individuals
PGP000620 |
Sun X et al. Cancer Res (2024)
Reported Trait: Triple negative breast cancer compared to luminal-like breast cancer Odds ratio (OR, high vs low tertile): 2.62 [1.44, 4.75] Age at initial pathologic diagnosis of breast cancer, pathologic stage

Evaluated Samples

PGS Sample Set ID
(PSS)
Phenotype Definitions and Methods Participant Follow-up Time Sample Numbers Age of Study Participants Sample Ancestry Additional Ancestry Description Cohort(s) Additional Sample/Cohort Information
PSS011672 The molecular intrinsic subtypes of breast cancer were determined following the strategy of Giovanni's work using the PAM50 classifier in the TCGA-BRCA. Basal-like and luminal-like breast cancer were determined by PAM50.
[
  • 108 cases
  • , 565 controls
]
European TCGA
PSS011672 Triple-negative breast cancer (TNBC) was defined as ER negative, PR negative and HER2 negative. The luminal breast cancer was defined as ER and/or PR positive.
[
  • 2,321 cases
  • , 6,874 controls
]
African American or Afro-Caribbean AABCG